Founded in 1949, The Leukemia & Lymphoma Society (LLS) is the world's largest voluntary health agency dedicated to fighting blood cancer. Its work spans the full spectrum of patient support, from funding research and providing financial assistance to offering educational resources and advocating for public policy. The organization operates with a global geographic presence.
LLS has invested nearly $1.5 billion in research since its inception, funding lifesaving treatments for blood cancers. The society also runs programs that provide free information and support services to patients and families, and helps cover treatment costs and non-medical expenses through financial assistance.
A central part of its mission is advocacy, working to ensure patient access to quality, affordable, coordinated care. The organization's strategic vision includes a bold goal to enable patients with blood cancer to gain more than one million years of life by 2040, extending its focus beyond survival to helping patients thrive.